TERN

2.10

9.87% -0.23

Dopo l'orario di chiusura: 2.10

Terns Pharmaceuticals Inc (TERN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.33

Aprire:

$2.24

Volume 24 ore:

1.44M

Relative Volume:

1.24

Capitalizzazione di mercato:

$183.33M

Reddito:

Utile/perdita netta:

$-95.90M

Rapporto P/E:

-1.5909

EPS:

-1.32

Flusso di cassa netto:

$-79.09M

1 W Prestazione:

-28.08%

1M Prestazione:

-40.17%

6M Prestazione:

-74.61%

1 anno Prestazione:

-61.75%

Intervallo 1D:

$2.08

$2.29

Intervallo di 1 settimana:

$2.08

$2.88

Portata 52W:

$2.08

$11.40

Terns Pharmaceuticals Inc Stock (TERN) Company Profile

Nome

Terns Pharmaceuticals Inc

Settore

Healthcare (1162)

Industria

Biotechnology (673)

Telefono

650-525-5535 EXT.101

Indirizzo

1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

TERN's Discussions on Twitter

Confronta TERN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TERN Terns Pharmaceuticals Inc	2.10	183.33M	0	-95.90M	-79.09M	-1.32
VRTX Vertex Pharmaceuticals Inc	474.62	121.88B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	573.45	62.69B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	555.11	33.86B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	235.74	30.51B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	238.51	25.69B	3.81B	-644.79M	-669.77M	-6.24

Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-28	Iniziato	William Blair	Mkt Perform
2024-10-31	Iniziato	Oppenheimer	Outperform
2023-06-22	Iniziato	Mizuho	Buy
2023-06-07	Iniziato	Jefferies	Buy
2023-05-31	Iniziato	ROTH MKM	Buy
2023-05-08	Iniziato	BMO Capital Markets	Outperform
2023-02-14	Iniziato	JMP Securities	Mkt Outperform
2023-02-07	Iniziato	UBS	Buy
2022-09-12	Iniziato	H.C. Wainwright	Neutral
2021-09-14	Ripresa	Goldman	Buy
2021-03-02	Iniziato	Cowen	Outperform
2021-03-02	Iniziato	Goldman	Buy
2021-03-02	Iniziato	JP Morgan	Overweight

Mostra tutto

Terns Pharmaceuticals Inc Borsa (TERN) Ultime notizie

Apr 03, 2025

Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN) - Yahoo Finance

Apr 03, 2025

Apr 02, 2025

Terns pharmaceuticals chief medical officer sells $2,365 in stock - Investing.com Australia

Apr 02, 2025

Terns Pharmaceuticals Reports Inducement Grant To New Employees Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 02, 2025

Terns Pharmaceuticals stock hits 52-week low at $2.5 By Investing.com - Investing.com South Africa

Apr 02, 2025

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Apr 02, 2025

Terns Pharmaceuticals Attracts Top Talent with 611,000-Share Equity Package - Stock Titan

Apr 02, 2025

Terns Pharmaceuticals stock hits 52-week low at $2.5 - Investing.com India

Apr 02, 2025

Apr 01, 2025

Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN

Apr 01, 2025

Mar 31, 2025

Insider Purchases Worth US$5.17m See Losses As Terns Pharmaceuticals Market Value Drops To US$255m - simplywall.st

Mar 31, 2025

HighTower Advisors LLC Invests $468,000 in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 31, 2025

Mar 28, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $18.30 Average Price Target from Analysts - Defense World

Mar 28, 2025

Mar 27, 2025

Terns Pharmaceuticals Reports 2024 Progress and Outlook - TipRanks

Mar 27, 2025

Mar 26, 2025

Terns Pharmaceuticals stock hits 52-week low at $3.08 By Investing.com - Investing.com South Africa

Mar 26, 2025

All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy - MSN

Mar 26, 2025

Terns Pharmaceuticals stock hits 52-week low at $3.08 - Investing.com

Mar 26, 2025

Mar 25, 2025

Bank of New York Mellon Corp Raises Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 25, 2025

Mar 24, 2025

Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 24, 2025

Mar 23, 2025

Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Perform Rating from William Blair - Defense World

Mar 23, 2025

Mar 20, 2025